Cost-effectiveness analysis of urine screening for drug of abuse in Kerman Medical University Central Laboratory in 2002

AUTHORS

Nozar Nakhaei 1 , * , Kouros Divsalar 2 , Ali Hasibi 3

1 Associate Professor Department of Community Medicine, Kerman University of Medical Sciences, Kerman, Iran.

2 Expert of Pertaining to Research, Kerman University of Medical Sciences, Kerman, Iran.

3 Medical Laboratory Technologist, Kerman University of Medical Sciences, Kerman, Iran.

How to Cite: Nakhaei N, Divsalar K, Hasibi A. Cost-effectiveness analysis of urine screening for drug of abuse in Kerman Medical University Central Laboratory in 2002, Hormozgan Med J. 2006 ; 10(3):e90145.

ARTICLE INFORMATION

Hormozgan Medical Journal: 10 (3); e90145
Published Online: June 09, 2006
Article Type: Research Article
Received: October 03, 2004
Accepted: June 09, 2006

Crossmark

CHEKING

READ FULL TEXT
Abstract

Introduction: Urine drug testing continues to be an important screening tool in
our country. This study was conducted to assess the cost-effectiveness of opioids
use screening programmes: premarital, preemployment, police detainees,
‘Harasat” referrals and private sector employees.
Methods: Consumable costs data were obtained by examining records. Personnel
costs were obtained through interviews with service providers and supervisors.
Overhead costs were allocated based on the portion of space used by opioid
testing services. For calculation of cost-effectiveness ratio of the screening
programs, the total direct cost of each program was divided by the total number
of positive TLCs.
Results: In total, 64698 individuals were screened by means of the above five
programs. 3460 (5.3%) subjects were confirmed by Rapid Screening Assay
(RSA) and Thin Layer Chromatography (TLC). Excluding capital costs, police
detainees screening program was the most cost-effective. Excluding capital costs
the break even point was at 2 percent.
Conclusion: Altogether individualized screening programs for opioid use would
be cost-effective even at a lower prevalence, and should be continued.

Keywords

Opioid Peptides – Urinalysis - Cost-effectiveness Analysis

© 2006, Hormozgan Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    References are included in the PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: